CIK 0001638287
- Non-accelerated filer
- Smaller reporting company
MetaVia Inc.
Sign in to watch- Ticker
- MTVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472389984
- Phone
- +1 857-702-9600
- Business address
- 545 CONCORD AVENUE, SUITE 210, CAMBRIDGE, MA, 02138
- Former names
- NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 19 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-09-30 | Sooch Mina President & CEO | Grant or award · Employee Stock Option (right to buy) | +120,000 | 480,000 | ||
| 2016-08-10 | Hawryluk P. Kent Director | Conversion | +7,457 | 7,457 | ||
| 2016-08-10 | Hawryluk P. Kent Director | Other acquisition | +816 | $6.71 | $5K | 8,273 |
| 2016-08-10 | Hawryluk P. Kent Director | Conversion | +23,616 | $6.71 | $158K | 31,889 |
| 2016-08-10 | Hawryluk P. Kent Director | Purchase | +25,000 | $10.00 | $250K | 56,889 |
| 2016-08-10 | Hawryluk P. Kent Director | Conversion · Series A Convertible Preferred Stock | −7,457 | 0 | ||
| 2016-08-10 | Hawryluk P. Kent Director | Conversion · 8% Convertible Subordinated Promissory Notes | −0 | 0 | ||
| 2016-08-10 | SASSINE ANDY Director | Conversion | +75,080 | 75,080 | ||
| 2016-08-10 | SASSINE ANDY Director | Other acquisition | +8,212 | $6.71 | $55K | 83,292 |
| 2016-08-10 | SASSINE ANDY Director | Conversion | +31,853 | $6.71 | $214K | 115,145 |
| 2016-08-10 | SASSINE ANDY Director | Conversion · Series A Convertible Preferred Stock | −75,080 | 0 | ||
| 2016-08-10 | SASSINE ANDY Director | Conversion · 8% Convertible Subordinated Promissory Notes | −0 | 0 | ||
| 2016-08-10 | LICHTINGER PEDRO Director | Conversion | +39,274 | $6.71 | $263K | 39,274 |
| 2016-08-10 | LICHTINGER PEDRO Director | Purchase | +10,000 | $10.00 | $100K | 49,274 |
| 2016-08-10 | LICHTINGER PEDRO Director | Conversion · 8% Convertible Subordinated Promissory Note | −0 | 0 |
Page 7 of 7 · 135 trades